Member Info for MisterPositive

Back in Sep 2025 when this jumped in just 2 weeks from 1.40p to 5.50p intra-day High.

Expect this to re-test 5.50p and go even higher this time around.

Added more again today while still at the lows.

News due any day now.

MMs won't be able to handle this with low amount of shares in free float.

Given how fast Pharma stocks jump.

Gold price rebounding nicely as expected.

Added few more again today at these prices before next RNS lands here. Any day now.

Won't stay low forever.

Https://www.kitco.com/news/off-the-wire/2026-03-03/investor-interest-greenlands-mining-has-increased-trumps-threats

"At this year’s Prospectors and Developers Association of Canada mining conference in Toronto, which runs until Wednesday, Greenland brought a delegation of over 20 mining companies.

Benjamin Gallezot, France’s interministerial delegate for ores and metals, said France was ready to take a minority equity stake in mining projects in Greenland to support their development."

I personally would also like GEO to make a start with Gorge deposit which looks very promising with high grades vs Juno which they can follow up later on.

On PEL94 licence, pretty sure a deal will be done soon as they can finalise all deal terms mainly what Working interest of the 78% they willing to give to the potential farm in partner.

Many mining stocks today been down 9%-12%

Alien was not an exception. Was across the board

IBM

We will see where the share price is by Christmas

Should be well north of today's price.

People can use their Negative headers but SILVER BULL case is well intact. This is just temporary

News incoming by the looks !!

MMs doing the FINAL flush today to grab some cheap shares before RNS.

OTC listing is different to Nasdaq listing.

Two very different things.

Typically takes 8 weeks. Will keep an eye here.

In the meantime CDL and GENI worth a look in my opinion, both with explosive Upside 5-10 bags. Please DYOR

The cardiovascular device market in New York State is a significant segment of the broader U.S. market, driven by a high prevalence of cardiovascular diseases (CVDs)—the leading cause of death in the state—and a large, aging population. While specific, isolated dollar values for New York State alone are rarely highlighted in global reports, it is consistently identified as a key regional driver within the U.S. market, which was valued at approximately $17.68 billion in 2024 and is projected to grow to over $30 billion by 2033.

Regional Dominance:

New York is specifically noted as a key, top-performing state for cardiovascular device adoption alongside California and Florida.

Matthew Walls, GENinCode Chief Executive Officer said: "Following careful evaluation by the New York State Department of Health, we are delighted to receive CARDIO inCode-Score® test approval to commercially promote CARDIO inCode-Score® for genetic risk prediction of heart disease in the New York State. The approval also provides further support for our FDA De Novo assessment."

Elizabeth Hill is turning out to be a HUGE deposit extending way beyond the boundaries of the historic HIGH GRADE silver mine.

With Silver price expected to Take Off....should coincide perfectly here.

STRONG BUY......NO Brainer.

2026 is looking great with so much news to come

Expect this to start moving higher ahead of the NASDAQ listing as folk start taking positions.

We should see a re-test of 1.30 in coming days.

I see this trading at +5p or higher in Q2.

GENinCode (AIM: GENI) has secured major international distribution deals, most notably a collaboration with Thermo Fisher Scientific to manufacture and distribute its CARDIO inCode-Score® test for heart disease in the US, Europe, Middle East, and Africa. They are also expanding into Latin America via a partnership with Sohin Genetics in Mexico.

UK Investor Magazine

+2

Key Distribution and Commercial Agreements (as of early 2026):

Thermo Fisher Scientific (US & EMEA): A strategic partnership announced in December 2025 to commercialize, manufacture, and distribute the CARDIO inCode-Score® polygenic risk score test. This includes supporting the transition from a lab-developed test (LDT) to full FDA-approved distribution.

Sohin Genetics (Mexico): A commercial agreement to distribute the CARDIO inCode-Score® test through Sohin’s network of clinics and hospitals in Mexico, targeting the Latin American market.

California Irvine Labs: Continued growth in the US market through direct, existing laboratory partnerships, which are already providing increasing test revenues.

UK Investor Magazine

+5

These partnerships aim to scale the adoption of GENinCode's cardiovascular risk assessment technology, with a particular focus on expanding access to their CE-marked and FDA-targeted products.

IMM did more than 10 bags between Aug and Sep last year from lows to High

Aug 2025......1.50p

Sep 2025......19.40p

GENI target market is HUGE with distribution deals in place covering both the USA and Mexico plus Latin America.

Surely GENI can repeat what IMM did last year.

Placing shares from January must be close to being cleared now.

Moving to sticky hands now. Total shares 753m

One of the fastest 10 baggers around on next RNS in my opinion.

MCap only £8m ??

Of which £3.5m is CASH raised on 21 Jan 2026

Insane....this is SIGNIFICANTLY UNDERVALUED especially having already received NEW YORK state approval for $500 per test targeting $10.5B market

Agree with what CDL potentially sitting on MCap of £10m here is way too low.

Next RNS should UNLOCK the value and trigger the HUGE Re-rate that is OVERDUE here.

Massive value currently trapped here is waiting to be unlocked like a coiled spring.

Just wait for NASDAQ listing expected on 18 March

Then watch this go.

Update on Disko (monster deposit) Expected to be drilled in Q2 followed by Janeson Land oil drill.

Hydrogen Valley (Italy) update due also to get more visibility on near term Cash flow to start.